Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,553.92
(
-0.80%
)
US TECH 100
23,437.60
(
-1.19%
)
Dow Jones
45,812.34
(
-0.45%
)
Brent Oil
106.05
(
1.55%
)
Bitcoin
70,231.98
(
0.48%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: AlpineBV_Miller post# 62246

Tuesday, 12/22/2009 9:24:40 PM

Tuesday, December 22, 2009 9:24:40 PM

Post# of 257262

The ESPR drugs were notoriously difficult to manufacture.

From today’s PR (#msg-44785558):

Since that time [of the ESPR acquisition], Pfizer has moved development forward with improvements to the original manufacturing process.

Regards, Dew


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today